As of Feb 24
| -0.20 / -3.81%|
The 2 analysts offering 12-month price forecasts for Caladrius Biosciences Inc have a median target of 6.75, with a high estimate of 7.00 and a low estimate of 6.50. The median estimate represents a +33.66% increase from the last price of 5.05.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.